Search the PBPK Model Repository

Quickly find freely available drug and population models in our PBPK model repository.

The models provided have been collated from published examples which authors have shared in our Published Model Collection or developed as part of various global health projects in our Global Health Collection. This search facility searches both model collections simultaneously.

To contribute published user compound and/or population files, upload your files here: Upload Model Files

Searching Tips

You can use a * character as a wildcard at the end of a alphanumeric search term. The search term must start with at least one character before the wildcard. E.g., Rifam* will get you “Rifampicin” and “Rifampin”.
You can also use a * character as a wildcard in the middle of a alphanumeric search term. The search term must still start with at least one character before the wildcard. E.g., Rif*in will also get you “Rifampicin” and “Rifampin” .
You can also use a * character as a wildcard at the start of a alphanumeric search term. However you must use forward slashes to delimit the search term and use a point before the wildcard. E.g., /.*picin/ will only get you “Rifampicin”.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Found 94 Matches

Tenofovir PBPK Model Review 2020

Model Files Publication

Tenofovir PBPK Model Review 2020

Search Score: 2

Methotrexate_RES_V17R1_Simcyp_20180228

Model Files Publication

Simcyp developed Methotrexate compound file. Compound summary included. This was developed as a research file and its current status and limitations are outlined in summary document.

Search Score: 2

Cobicistat PBPK Model Review 2020

Model Files Publication

Cobicistat PBPK Model Review 2020

Search Score: 2

MefenamicAcid_Dapagliflozin_V15R1_Pfizer_20220726

Model Files Publication

Mefenamic acid and dapagliflozin/healthy volunteer. This workspace simulates the UGT mediated DDI after multiple dose administration of UGT inhibitor mefenamic acid. The workspace shows Dapaglifazin as substrate of UGTA9 and UGT2B7. Mefenamic Acid is used in the inhibitor position and Ki values against UGT1A9 and UGT2B7 are included in the workspace.

Search Score: 2

Search the PBPK Model Repository

Searching Tips

Tenofovir PBPK Model Review 2020

Methotrexate_RES_V17R1_Simcyp_20180228

Cobicistat PBPK Model Review 2020

MefenamicAcid_Dapagliflozin_V15R1_Pfizer_20220726

Your Privacy